Shared diagnostic genes and potential mechanism between PCOS and recurrent implantation failure revealed by integrated transcriptomic analysis and machine learning

被引:18
|
作者
Chen, Wenhui [1 ,2 ,3 ]
Yang, Qingling [1 ,2 ,3 ]
Hu, Linli [1 ,2 ,3 ]
Wang, Mengchen [1 ,2 ,3 ]
Yang, Ziyao [1 ,2 ,3 ]
Zeng, Xinxin [1 ,2 ,3 ]
Sun, Yingpu [1 ,2 ,3 ]
机构
[1] Zhengzhou Univ, Ctr Reprod Med, Affiliated Hosp 1, Zhengzhou, Peoples R China
[2] Zhengzhou Univ, Henan Key Lab Reprod & Genet, Affiliated Hosp 1, Zhengzhou, Peoples R China
[3] Zhengzhou Univ, Henan Prov Obstetr & Gynecol Dis Reprod Med Clin R, Affiliated Hosp 1, Zhengzhou, Peoples R China
来源
FRONTIERS IN IMMUNOLOGY | 2023年 / 14卷
基金
中国国家自然科学基金; 国家重点研发计划;
关键词
PCOS; RIF (Recurrent Implantation Failure); integrated transcriptomic analysis; machine learning; TCA cycle; ENDOMETRIAL RECEPTIVITY; EXPRESSION PROFILES; DETERMINANTS; INFLAMMATION; METABOLISM; DISORDERS; PREGNANCY; PATHWAYS; HEALTH;
D O I
10.3389/fimmu.2023.1175384
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Polycystic ovary syndrome (PCOS) is a complex endocrine metabolic disorder that affects 5-10% of women of reproductive age. The endometrium of women with PCOS has altered immune cells resulting in chronic low-grade inflammation, which attribute to recurrent implantation failure (RIF). In this study, we obtained three PCOS and RIF datasets respectively from the Gene Expression Omnibus (GEO) database. By analyzing differentially expressed genes (DEGs) and module genes using weighted gene co-expression networks (WGCNA), functional enrichment analysis, and three machine learning algorithms, we identified twelve diseases shared genes, and two diagnostic genes, including GLIPR1 and MAMLD1. PCOS and RIF validation datasets were assessed using the receiver operating characteristic (ROC) curve, and ideal area under the curve (AUC) values were obtained for each disease. Besides, we collected granulosa cells from healthy and PCOS infertile women, and endometrial tissues of healthy and RIF patients. RT-PCR was used to validate the reliability of GLIPR1 and MAMLD1. Furthermore, we performed gene set enrichment analysis (GSEA) and immune infiltration to explore the underlying mechanism of PCOS and RIF cooccurrence. Through the functional enrichment of twelve shared genes and two diagnostic genes, we found that both PCOS and RIF patients had disturbances in metabolites related to the TCA cycle, which eventually led to the massive activation of immune cells.
引用
收藏
页数:15
相关论文
共 30 条
  • [21] Comprehensive bioinformatics analysis identifies metabolic and immune-related diagnostic biomarkers shared between diabetes and COPD using multi-omics and machine learning
    Liang, Qianqian
    Wang, Yide
    Li, Zheng
    FRONTIERS IN ENDOCRINOLOGY, 2025, 15
  • [22] Genetic insights into the connection between pulmonary TB and non-communicable diseases: An integrated analysis of shared genes and potential treatment targets
    Mahjabeen, Amira
    Hasan, Md. Zahid
    Rahman, Md. Tanvir
    Islam, Md. Aminul
    Khan, Risala Tasin
    Kaiser, M. Shamim
    PLOS ONE, 2024, 19 (10):
  • [23] Integrated multi-omics analysis and machine learning identify hub genes and potential mechanisms of resistance to immunotherapy in gastric cancer
    Wang, Jinsong
    Feng, Jia
    Chen, Xinyi
    Weng, Yiming
    Wang, Tong
    Wei, Jiayan
    Zhan, Yujie
    Peng, Min
    AGING-US, 2024, 16 (08): : 7331 - 7356
  • [24] Identification of diagnostic genes and drug prediction in metabolic syndrome-associated rheumatoid arthritis by integrated bioinformatics analysis, machine learning, and molecular docking
    Huang, Yifan
    Yue, Songkai
    Qiao, Jinhan
    Dong, Yonghui
    Liu, Yunke
    Zhang, Meng
    Zhang, Cheng
    Chen, Chuanliang
    Tang, Yuqin
    Zheng, Jia
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [25] Potential Shared Mitochondrial-Related Gene Signatures and Molecular Mechanisms Between Polycystic Ovary Syndrome (PCOS) and Major Depressive Disorder (MDD): Evidence from Transcriptome Data and Machine Learning
    Liang, Huan
    Liu, Yi
    Zhang, Chunhua
    Qin, Yaoqin
    MOLECULAR BIOTECHNOLOGY, 2024, : 2628 - 2643
  • [26] Identification and validation of potential diagnostic signature and immune cell infiltration for NAFLD based on cuproptosis-related genes by bioinformatics analysis and machine learning
    Ouyang, Guoqing
    Wu, Zhan
    Liu, Zhipeng
    Pan, Guandong
    Wang, Yong
    Liu, Jing
    Guo, Jixu
    Liu, Tao
    Huang, Guozhen
    Zeng, Yonglian
    Wei, Zaiwa
    He, Songqing
    Yuan, Guandou
    FRONTIERS IN IMMUNOLOGY, 2023, 14
  • [27] Machine learning analysis of gene expression profiles of pyroptosis-related differentially expressed genes in ischemic stroke revealed potential targets for drug repurposing
    Hei, Changchun
    Li, Xiaowen
    Wang, Ruochen
    Peng, Jiahui
    Liu, Ping
    Dong, Xialan
    Li, P. Andy
    Zheng, Weifan
    Niu, Jianguo
    Yang, Xiao
    SCIENTIFIC REPORTS, 2025, 15 (01):
  • [28] Identification and validation of potential diagnostic signature and immune cell infiltration for HIRI based on cuproptosis-related genes through bioinformatics analysis and machine learning
    Xiao, Fang
    Huang, Guozhen
    Yuan, Guandou
    Li, Shuangjiang
    Wang, Yong
    Tan, Zhi
    Liu, Zhipeng
    Tomlinson, Stephen
    He, Songqing
    Ouyang, Guoqing
    Zeng, Yonglian
    FRONTIERS IN IMMUNOLOGY, 2024, 15
  • [29] Identification and validation of the diagnostic signature associated with immune microenvironment of acute kidney injury based on ferroptosis-related genes through integrated bioinformatics analysis and machine learning
    Chen, Yalei
    Liu, Anqi
    Liu, Hunan
    Cai, Guangyan
    Lu, Nianfang
    Chen, Jianwen
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2023, 11
  • [30] Identification of Hub Genes Associated with Tumor-Infiltrating Immune Cells and ECM Dynamics as the Potential Therapeutic Targets in Gastric Cancer through an Integrated Bioinformatic Analysis and Machine Learning Methods
    Liu, Jie
    Cheng, Zhong
    COMBINATORIAL CHEMISTRY & HIGH THROUGHPUT SCREENING, 2023, 26 (04) : 653 - 667